期刊文献+

应用抗抑郁药配合常规治疗冠心病患者临床疗效的探讨

Study of clinical efficacy of the application of combining antidepressants and conventional treatment of patients with coronary disease
下载PDF
导出
摘要 目的探讨抗抑郁药的应用对冠心病患者临床疗效的影响。方法对筛选出的60例冠心病合并抑郁情绪的患者按随机原则分为两组,实验组和对照组各30例。实验组进行冠心病常规药物治疗的同时加用抗抑郁药,对照组只进行常规药物治疗,两组分别于治疗前、治疗8周后各进行一次心电图检查和抑郁自评量表(SDS)测定,两组于治疗4周后再行一次SDS的测定,将所有的检查、测定结果列表进行比较。结果实验组心电图症状的改变、SDS的评分改变与对照组比较差异有统计学意义(P<0.05或0.01)。结论抗抑郁药配合常规治疗冠心病的疗效显著,值得在临床冠心病治疗中推广应用。 Objective To investigate the efficacy of the application of antidepressants on patients with coronary disease.Methods 60 patients with coronary disease concurrent with depression were selected.According to statistics,they were randomly divided into two groups:the experimental group and the control group,with 30 members in each group.The experimental group was treated with conventional coronary disease therapy plus antidepressants,while the control group was treated only with conventional therapy.Each group had electrocardiographic examination and SDS tests before treatment and after 8 weeks of the experiment they had examinations and tests again.SDS tests were also conducted after 4 weeks of the treatment.All the results were collected in the end for comparing. Results There was statistical difference in ECG changes and SDS scores of the experimental group and the control group(P0.05 or 0.01). Conclusion Antidepressants can enhance the effects of conventional coronary disease treatment.Such therapy is worth popularizing in the clinical treatment of coronary heart disease.
作者 刘中春
出处 《右江医学》 2011年第5期553-555,共3页 Chinese Youjiang Medical Journal
关键词 冠心病 抑郁 心电图 coronary disease depression ECG
  • 相关文献

参考文献5

二级参考文献22

  • 1王旭梅,白雪,沈娜,王旭红,李艳辉.冠心病患者心理健康状况和个性心理特征的关系[J].中国临床康复,2004,8(24):4986-4987. 被引量:5
  • 2陈建平,顾卫平,卢尔滨,杨丽春.冠心病患者情绪障碍调查[J].中国心理卫生杂志,1997,11(3):142-144. 被引量:144
  • 3薛一涛 吴彤 苏文革 等.运用选择性冠状动脉造影的方法研究个性特征与冠心病的关系[J].中华心血管病杂志,2007,10(3):26-27.
  • 4Kelly D, Squire IB, Khan SQ, et al. C -terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial irffaretion [J].J Card Fail, 2008, 14 (9): 739-745.
  • 5Neuhold S, Huelsmann M, Strunk G, et al. Comparison of copeptin, B - type natriuretic peptide, and amino - terminal pro - B - type natriuretic peptide in patients with chronic heart failure : prediction of death at different stages of the disease [J]. J Am Coil Cardiol, 2008, 52 (4) : 266 -272.
  • 6Palazzuoli A, Deckers J, Calabro A, et al. Brain natriuretic peptide and other risk markers for outcome assessment in patients with non - ST - elevation coronary syndromes and preserved systolic function [ J]. Am J Cardiol, 2006, 28 (10): 1322-1328.
  • 7Galvani M, Ferrini D, Ottani F, et al. Natriuretic peptides for risk stratification of patients with acute coronary syndromes [ J ]. Eur J Heart Fail, 2004, 6 (3): 327-333.
  • 8Khan SQ, Dhillon QS, O'Brien RJ, et al. C - Terminal pro - vasopressin (Copeptin) as a novel and prognostic marker in acute myocardial infarction Leicester acute myocardial infarction peptide (LAMP) study [J]. Circulation, 2007, 115 (16): 2103-2110.
  • 9Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease [J]. Am J Cardiol, 1983, 51 (3) : 606.
  • 10Foote RS, Pearlman JD, Siegel AH, et al. Detection of exercise induced ischemia by changes in B -type natriuretic peptides [J].J Am Coll Cardiol, 2004, 44 (10) : 1980 -1987.

共引文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部